Emcure Pharmaceuticals Fully Absorbs Gennova Biopharmaceuticals in Biologics Consolidation Move

Emcure completes full ownership integration of mRNA vaccine developer Gennova, centralising its biosimilar and complex biologics operations under one roof post-IPO amid India's biosimilar export push.

ndtv-profit-business · 7/13/2026, 5:17:56 PM · Ask about this →